Phreesia, Inc. PHR
Set alert
At close · Oct 30
After hours · Oct 30, 4:01 PM ET
- YTD
- -26.48%
- 1 year
- -45.10%
- Open
- 12.59
- Prev close
- 12.53
- Mkt cap
- 772.16M
- Vol
- 597.73K
- Avg vol
- 734.77K
- EPS
- 0.17
- P/E
- 73.18
- Div yield
- 0.00%
More statistics
- Low
- 12.20
- High
- 12.79
- Forward P/E
- -25.76
- Beta
- 0.64
- Short ratio
- 7.35
- Inst. own
- 104.22%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 22.08
- 200-d avg
- 25.25
- 1y target
- 32.47
5D chart
Signals (99)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bullish | Oct 29, 3:50 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:40 PM | 3 days ago |
| SMA: Bearish | Oct 29, 3:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 3:20 PM | 3 days ago |
| RSI: Overbought | Oct 29, 2:50 PM | 3 days ago |
| RSI: Overbought | Oct 29, 2:40 PM | 3 days ago |
| RSI: Overbought | Oct 29, 2:00 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 1:45 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:40 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 1:20 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:15 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 1:00 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:25 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:15 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:10 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:05 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:00 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:50 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:45 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:40 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:40 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 9:40 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 9:35 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:30 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 3:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:05 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:35 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 2:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:25 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 2:25 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 2:20 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:00 PM | 4 days ago |
| RSI: Overbought | Oct 28, 1:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:20 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:15 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:05 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 12:05 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:00 PM | 4 days ago |
| SMA: Bullish | Oct 28, 11:50 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:55 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:50 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:45 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:45 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:45 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:40 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 10:40 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:35 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:20 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:45 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:35 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 9:35 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 9:30 AM | 4 days ago |
| RSI: Oversold | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 27, 3:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:20 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 3:20 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 2:35 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 2:30 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 2:25 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 2:15 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 1:50 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:40 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:35 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 1:05 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 12:35 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:10 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:10 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:05 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:00 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 11:15 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:50 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 10:50 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:45 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:35 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:35 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:35 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 26, 3:50 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 3:50 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:40 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:00 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:00 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:55 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:35 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:10 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:00 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 12:35 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:30 PM | 6 days ago |
| SMA: Bearish | Oct 26, 10:30 AM | 6 days ago |
News
1 day ago seekingalpha.com
Phreesia: Q3 Must Prove That Growth Can Drive Higher Profitability
Phreesia is rated Buy with a $14.8 price target, reflecting undervaluation versus peers and improving profitability. Q2 revenue grew 10.4% YoY to $129.5M, driven by payment solutions, but…
2 weeks ago defenseworld.net
Head-To-Head Comparison: Phreesia (NYSE:PHR) & National Research (NASDAQ:NRC)
National Research (NASDAQ: NRC - Get Free Report) and Phreesia (NYSE: PHR - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two…
-
2 weeks ago benzinga.com
Barclays Maintains Equal-Weight on Phreesia, Raises Price Target to $11
Barclays analyst Glen Santangelo maintains Phreesia (NYSE:PHR) with a Equal-Weight and raises the price target from $10 to $11.
3 weeks ago benzinga.com
Argenx, Caribou Biosciences And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures fell, with Dow futures down 450 points. Argenx sank 8.7% after a Sjögren’s trial was halted for futility; others also slid.
3 weeks ago businesswire.com
Phreesia's Michael Rasbury Named to Becker's 2026 List of Rising Stars: Healthcare Leaders Under 40
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia's Michael Rasbury, VP of AccessOne Solutions, named to Becker's Hospital Review's 2026 Rising Stars: Healthcare Leaders Under 40 list.
1 month ago businesswire.com
Phreesia Named to TIME's 2026 List of the World's Top HealthTech Companies
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, has been named to TIME's list of the World's Top HealthTech Companies of 2026.…
1 month ago defenseworld.net
Phreesia (NYSE:PHR) General Counsel Allison Hoffman Sells 6,662 Shares of Stock
Phreesia, Inc. (NYSE: PHR - Get Free Report) General Counsel Allison Hoffman sold 6,662 shares of the stock in a transaction dated Monday, September 21st. The stock was sold at an average price of…
1 month ago businesswire.com
Phreesia's ProviderConnect Audiences are Now Available in the DeepIntent Audience Marketplace
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia's ProviderConnect audiences are now available in the DeepIntent Audience Marketplace.
1 month ago fool.com
Why Phreesia Stock Got Knocked Down Today
This added to lingering negative sentiment following the company's latest earnings release. Investors didn't like the fact that it whiffed on earnings.
-
1 month ago benzinga.com
DA Davidson Maintains Buy on Phreesia, Lowers Price Target to $13
DA Davidson analyst Clark Wright maintains Phreesia (NYSE:PHR) with a Buy and lowers the price target from $14 to $13.
-
1 month ago benzinga.com
Baird Maintains Neutral on Phreesia, Raises Price Target to $11
Baird analyst Joseph Vruwink maintains Phreesia (NYSE:PHR) with a Neutral and raises the price target from $10 to $11.
1 month ago fool.com
Why Phreesia Stock Tumbled Today
Although its net income rose sharply, analysts expected better. On a brighter note, the company slightly topped the consensus pundit estimate for revenue.
-
1 month ago benzinga.com
Phreesia Files Shelf Prospectus For Offering; Size Not Disclosed
https://www.sec.gov/Archives/edgar/data/1412408/000162828026060497/phreesia-sx3asr2026.htm
1 month ago benzinga.com
These Analysts Revise Their Forecasts On Phreesia After Q2 Results
Phreesia Inc (NYSE:PHR) on Wednesday reported mixed second-quarter financial results.
1 month ago benzinga.com
These Analysts Revise Their Forecasts On Phreesia After Q2 Results
Phreesia's Q2 EPS missed estimates, while sales beat. FY27 guidance held; shares fell 5.6%. Analysts kept bullish targets, Wells Fargo raised to $10.
-
1 month ago benzinga.com
Wells Fargo Maintains Equal-Weight on Phreesia, Raises Price Target to $10
Wells Fargo analyst Stan Berenshteyn maintains Phreesia (NYSE:PHR) with a Equal-Weight and raises the price target from $9 to $10.
2 months ago seekingalpha.com
Phreesia, Inc. (PHR) Q2 2027 Earnings Call Transcript
Phreesia, Inc. (PHR) Q2 2027 Earnings Call Transcript
2 months ago zacks.com
Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended July 2026, but it may be worthwhile to compare some of its key metrics to Wall Street…
2 months ago zacks.com
Phreesia (PHR) Q2 Earnings and Revenues Lag Estimates
Phreesia (PHR) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.01 per share a year ago.
2 months ago marketbeat.com
Phreesia Q2 Earnings Call Highlights
Phreesia NYSE: PHR reported second-quarter fiscal 2027 revenue growth and continued profitability expansion, while maintaining its full-year revenue and adjusted EBITDA outlook. The company said it…
2 months ago benzinga.com
Transcript: Phreesia Q2 2027 Earnings Conference Call
Phreesia (NYSE:PHR) reported second-quarter financial results on Wednesday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga…
2 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Gelteq (NASDAQ:GELS) stock moved upwards by 20.3% to $0.84 during Wednesday's after-market session. The company's market cap stands at $5.6 million. Nyxoah (NASDAQ:NYXH) shares increased by…
-
2 months ago benzinga.com
Phreesia Affirms FY2027 Sales Guidance of $510.000M-$520.000M vs $515.008M Est
Phreesia (NYSE:PHR) affirms FY2027 sales outlook from $510.000 million-$520.000 million to $510.000 million-$520.000 million vs $515.008 million estimate.
-
2 months ago benzinga.com
Phreesia Q2 EPS $0.03 Misses $0.10 Estimate, Sales $129.458M Beat $129.069M Estimate
Phreesia (NYSE:PHR) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.10 by 70 percent. This is a 200 percent increase over earnings of $0.01 per share…
2 months ago businesswire.com
Phreesia Announces Second Quarter Fiscal 2027 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2026.…
2 months ago defenseworld.net
Deutsche Bank AG Invests $538,000 in Phreesia, Inc. $PHR
Deutsche Bank AG bought a new position in shares of Phreesia, Inc. (NYSE: PHR) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange…
2 months ago defenseworld.net
Contrasting DarioHealth (NASDAQ:DRIO) and Phreesia (NYSE:PHR)
Phreesia (NYSE: PHR - Get Free Report) and DarioHealth (NASDAQ: DRIO - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses…
2 months ago benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
2 months ago defenseworld.net
Phreesia, Inc. $PHR Stake Lessened by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP lessened its holdings in Phreesia, Inc. (NYSE: PHR) by 22.9% in the undefined quarter, according to the company in its most recent disclosure with the Securities and…
2 months ago defenseworld.net
Phreesia (NYSE:PHR) Shares Gap Up – Here’s Why
Phreesia, Inc. (NYSE: PHR - Get Free Report)'s stock price gapped up before the market opened on Friday. The stock had previously closed at $11.42, but opened at $12.60. Phreesia shares last traded…
2 months ago businesswire.com
Phreesia Sets Release Date for Fiscal Second Quarter 2027 Results
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia will release its fiscal second quarter 2027 financial results after the close of market trading on Wednesday, Sept. 2, 2026.
2 months ago globenewswire.com
PHREESIA, INC. (NYSE: PHR) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP , a nationally recognized investor rights law firm, announces that it is investigating potential breaches of fiduciary duty by…
-
5 months ago benzinga.com
Truist Securities Maintains Hold on Phreesia, Raises Price Target to $12
Truist Securities analyst Jailendra Singh maintains Phreesia (NYSE:PHR) with a Hold and raises the price target from $11 to $12.
-
5 months ago benzinga.com
Citigroup Maintains Neutral on Phreesia, Raises Price Target to $12
Citigroup analyst Daniel Grosslight maintains Phreesia (NYSE:PHR) with a Neutral and raises the price target from $10 to $12.
-
5 months ago benzinga.com
Canaccord Genuity Maintains Buy on Phreesia, Lowers Price Target to $16
Canaccord Genuity analyst Richard Close maintains Phreesia (NYSE:PHR) with a Buy and lowers the price target from $22 to $16.
5 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
-
5 months ago benzinga.com
Market-Moving News for May 28th
SNOW: 38% | Snowflake shares are trading higher after the company reported better-than-expected Q1 financial results. Also, the company announced it signed a multi-year strategic collaboration…
5 months ago benzinga.com
Why Phreesia Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket
Phreesia (NYSE: PHR) shares rose in pre-market trading after better-than-expected sales results. Other gainers include Snowflake, Genius Group, and Astrotech.
-
5 months ago benzinga.com
Phreesia Q1 2027 Earnings Call Transcript
Phreesia Q1 2027 Earnings Call Transcript
-
5 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
5 months ago benzinga.com
Phreesia Affirms FY2027 Sales Guidance of $510.000M-$520.000M vs $515.698M Est
Phreesia (NYSE:PHR) affirms FY2027 sales outlook from $510.000 million-$520.000 million to $510.000 million-$520.000 million vs $515.698 million estimate.
-
5 months ago benzinga.com
Phreesia Q1 EPS $0.05, Inline, Sales $130.935M Beat $130.128M Estimate
Phreesia (NYSE:PHR) reported quarterly earnings of $0.05 per share which met the analyst consensus estimate. This is a 171.43 percent increase over losses of $(0.07) per share from the same period…
-
5 months ago benzinga.com
Wells Fargo Downgrades Phreesia to Equal-Weight, Lowers Price Target to $9
Wells Fargo analyst Stan Berenshteyn downgrades Phreesia (NYSE:PHR) from Overweight to Equal-Weight and lowers the price target from $15 to $9.
-
5 months ago benzinga.com
Barclays Downgrades Phreesia to Equal-Weight, Lowers Price Target to $10
Barclays analyst Glen Santangelo downgrades Phreesia (NYSE:PHR) from Overweight to Equal-Weight and lowers the price target from $24 to $10.
-
5 months ago benzinga.com
Phreesia Implements Restructuring Plan, Eliminates ~220 Positions To Reduce Operating Expenses And Align Costs With Business Priorities; Expects Plan Costs To Be Immaterial And Incurred In Fiscal Year 2027
On May 7, 2026, Phreesia, Inc. (the "Company") implemented a restructuring plan intended to reduce operating expenses and better align the Company's cost structure with its current business…
-
6 months ago benzinga.com
Keybanc Maintains Overweight on Phreesia, Lowers Price Target to $12
Keybanc analyst Brandon Nispel maintains Phreesia (NYSE:PHR) with a Overweight and lowers the price target from $15 to $12.
-
7 months ago benzinga.com
Citigroup Downgrades Phreesia to Neutral, Lowers Price Target to $10
Citigroup analyst Daniel Grosslight downgrades Phreesia (NYSE:PHR) from Buy to Neutral and lowers the price target from $25 to $10.
-
7 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
-
7 months ago benzinga.com
JP Morgan Downgrades Phreesia to Neutral, Lowers Price Target to $16
JP Morgan analyst Alexei Gogolev downgrades Phreesia (NYSE:PHR) from Overweight to Neutral and lowers the price target from $24 to $16.
7 months ago benzinga.com
This Rockwell Automation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Top Wall Street analysts changed outlook on top names. Needham downgrades CNTA, Baird downgrades PHR.